<DOC>
	<DOCNO>NCT00196079</DOCNO>
	<brief_summary>The ASPECT study Asian multicenter , randomize , control , triple-blinded study design evaluate ability Cook Incorporated Paclitaxel Eluting Supra G Coronary Stent reduce restenosis coronary artery .</brief_summary>
	<brief_title>The ASPECT Study - Asian Paclitaxel-Eluting Stent Clinical Trial</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>Patient must eligible undergo plan treatment single de novo lesion native coronary artery . Patient must acceptable candidate coronary artery bypass surgery . Patient must give sign informed consent . Patient agree return one month office visit ass cardiovascular status 46 month office visit ass cardiovascular status diagnostic angiogram . Patient le 18 year old . Patient history bleed diathesis coagulopathy refuse blood transfusion . The patient simultaneously participate another investigative interventional cardiovascular device drug study . Patient known hypersensitivity contraindication aspirin , Clopidogrel , stainless steel , sensitivity contrast dye . Patient pregnant . Patient medical condition may cause patient noncompliant protocol , confound result associate limited life expectancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>coronary artery</keyword>
	<keyword>stenosis</keyword>
	<keyword>drug elute stent</keyword>
	<keyword>stent</keyword>
</DOC>